Yingli Ma

Insider Reports History

Entity
Individual
Location
C/O Structure Therapeutics Inc., 611 Gateway Blvd., Suite 223, South San Francisco, CA
Signature
/s/ Jun Yoon, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Yingli Ma:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Structure Therapeutics Inc. CHIEF TECHNOLOGY OFFICER Stock Option (right to buy) 91.5K $729K $7.97 Mar 15, 2024 Direct
Structure Therapeutics Inc. CHIEF TECHNOLOGY OFFICER Ordinary Shares 36.7K Mar 15, 2024 Direct

Insider Reports Filed by Yingli Ma

Symbol Company Period Transactions Value $ Form Type Date Filed Role
GPCR Structure Therapeutics Inc. Mar 15, 2024 1 $0 4/A Mar 20, 2024 CHIEF TECHNOLOGY OFFICER
GPCR Structure Therapeutics Inc. Mar 15, 2024 2 $0 4 Mar 19, 2024 CHIEF TECHNOLOGY OFFICER
GPCR Structure Therapeutics Inc. Feb 2, 2023 0 $0 3 Feb 2, 2023 Chief Technology Officer